January 2021 Flashcards
(203 cards)
Efficacy of Baricitinib + Remdesivir for COVID?
NEJM DEC 2020
RCT by NIH
CONCLUSIONS: Baricitinib plus remdesivir was superior to remdesivir alone in 1) reducing recovery time and 2) accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation. The combination was associated with fewer serious adverse events.
Non significant in mortality
Patients receiving baricitinib had a median time to recovery of 7 days (95% confidence interval [CI], 6 to 8), as compared with 8 days (95% CI, 7 to 9) with control (rate ratio for recovery, 1.16; 95% CI, 1.01 to 1.32; P = 0.03), and a 30% higher odds of improvement in clinical status at day 15 (odds ratio, 1.3; 95% CI, 1.0 to 1.6). Patients receiving high-flow oxygen or noninvasive ventilation at enrollment had a time to recovery of 10 days with combination treatment and 18 days with control (rate ratio for recovery, 1.51; 95% CI, 1.10 to 2.08).
Kalil AC, Patterson TF, Mehta AK, et al. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N Engl J Med. 2020 Dec 11. doi: 10.1056/NEJMoa2031994.
What patient population is Baricitinib + Remdesivir treatment beneficial for ?
COVID patients on high flow or non-invasive mechanical ventilation
Can Hydroxychloroquine act as an effective post exposure prophylaxis for contacts of COVID confirmed patients?
ANNALS OF INTERNAL MEDICINE DEC 2020
RCT
CONCLUSION: This rigorous randomized controlled trial among persons with recent exposure excluded a clinically meaningful effect of hydroxychloroquine as postexposure prophylaxis to prevent SARS-CoV-2 infection.
Among the 689 (89%) participants who were SARS-CoV-2 negative at baseline, there was no difference between the hydroxychloroquine and control groups in SARS-CoV-2 acquisition by day 14 (53 versus 45 events; adjusted hazard ratio, 1.10 [95% CI, 0.73 to 1.66]; P > 0.20). The frequency of participants experiencing adverse events was higher in the hydroxychloroquine group than the control group (66 [16.2%] versus 46 [10.9%], respectively; P = 0.026)
Barnabas RV, Brown ER, Bershteyn A, et al. Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial. Ann Intern Med. 2020 Dec 8. doi: 10.7326/M20-6519.
Funded by Bill Gates
FRAMEWORK QUESTION:
What is “post cardiac arrest syndrome”?
It is an inflammatory response caused by whole body reperfusion injury following a whole body ischemic event such as cardiac arrest
TIP: Think of cardiac arrest as ischemia to the entire body and ROSC as the trigger for reperfusion. Reperfusion is the principal trigger for the post cardiac arrest syndrome given the injury from oxidants
What are the major organs affected in “post cardiac arrest syndrome”?
1) Brain injury:
2) Post arrest cardiac dysfunction
3) Systemic shock - systemic inflammatory response syndrome
Describe the expected hemodynamic state of most patients soon after obtaining ROSC from cardiac arrest?
Circulatory shock that can lead to multiorgan failure
“Systemic inflammatory response syndrome” is almost universal following an arrest. Usually apparent with int 24 hours of cardiac arrest. Think of this as “whole body reperfusion injury”
What is the targeted temperature in Targeted Temperature Management?
AKA what does the celsius equate to in Fahrenheit
32 degrees to 34 degrees Celsius
Which ends up being 90 - 93
TRICK:
Celsius to Fahrenheit: Celsius X 2 + 30
TIP: Fahrenheit tends to be a higher number for the equivalent celsius. Fahrenheit has more letters in its spelling
How long does Targeted Temperature Management last?
12-24 hours only
What patients should Target Temperature Management be used for?
Patients who do not awaken after ROSC
What are the only absolute contraindications to targeted temperature management?
Pre-existing hypothermia (Defined as < 34 degrees (aka < 93 degrees Celsius)), Major bleeding, and Cyroglobulinemia
What are the main outcomes/benefits derived from Targeted Temperature Management?
Studies have shown benefit in 2 arenas:
1) Neurologic recovery
2) Mortality rate
How does shivering during the cooling process affect the efficacy of cooling?
It is counterproductive as it produces heat
What is the beneficial end point of Tocilizumab in COVID 19?
DEC 2020
NEJM EMPACTA TRIAL
RCT
Addition of tocilizumab to standard care reduces risk of composite of mechanical ventilation and death in adults from high-risk and mostly racial and ethnic minority populations hospitalized with COVID-19 pneumonia
Death, when measured alone, was no different between the 2 groups
Hence, its really reduced risk of mechanical ventilation
What is more likely to present with HA – ischemic stroke vs ICH?
ICH
What is the imaging of choice for intracerebral hemorrhage?
Non contrast CT is highly sensitive and specific
Clinical tip: Reason it is used in ischemic stroke to rule out hemorrhage
Tip: While CT head is not sensitive or specific for acute ischemic stroke, it is very sensitive and specific for ICH
What structure are make up the basal ganglia?
basal ganglia are the caudate, putamen, and globus pallidus in the cerebrum, the substantia nigra in the midbrain, and the subthalamic nucleus in the diencephalon.
Location of ICH helps narrow differential diagnosis of the cause. What is on the differential diagnosis of a patient who presents with ICH in a lobar distribution?
Amyloid Angiopathy
Dural AV fistula
AVM
Metastatic brain tumor
What part of the brain does hypertension- induced ICH usually present?
4 places:
1) Basal ganglia (Putamen, Globus pallidum)
2) Thalamus
3) Cerebellar hemisphere
4) Pons
Protip: The putamen is the #1 place for hypertensive ICH
Framework Question:
What is the general concern with high BP in the setting of ICH?
Higher blood pressure may cause expansion of the hematoma
Clinical tip: lower blood pressure is assumed to reduce size of hematoma, though no evidence
What is the goal BP for patients presenting with ICH?
- if systolic BP of 150-220 mm Hg and no contraindications to BP treatment, reduce systolic BP to about 140 mm Hg
- if systolic BP > 220 mm Hg, consider aggressive BP reduction with a continuous IV infusion and frequent BP monitoring
ATACH2, INTERACT Trial
What drug class is recommended when lowering BP in patients with ICH?
NON vasodilatory drugs – drugs that may vasodilate venous system may worsen ICH by increasing cerebral blood flow (not sure how)
Nicardipine
Clevidipine
Labetalol
Esmolol
CONFUSING since the first 2 drugs are vasodilatory, right?
What percent of strokes are caused by ICH?
10%
BUT: 35-45% of these patients are dead at 1 month! Hence, low incidence, high mortality
What is the presentation of the ICH in the putamen?
Contralateral hemiparesis
Eyes deviate AWAY from the lesion
Clinical tip: Putamen abuts the internal capsule, through which the corticospinal tract runs through, hence contralateral hemiplegia
What is the presentation of the ICH in the Thalamus?
Contralateral hemiparesis
Prominent sensory deficit of ALL modalities
Aphasia
Hemianopia
Specific eye findings
- deviation of both eyes to the nose (down and inward)
- Unequal pupils
- Absence of light reaction
- Skew deviation (unusual ocular deviation (strabismus), wherein the eyes move upward (hypertropia), but in opposite directions)
- Ispilateral horner syndrome - interesting that thalamus can lead to horner
- Absence of convergence
- Paralysis of upward gaze
- Retraction nystagmus (when looking upward, the eyes will move in and out of being crossed)
TIP: presentation of thalamic stroke may appear almost identical to MCA stroke + Eye findings
Clinical tip: Thalamus, like the putamen, abuts the internal capsule, through which the corticospinal tract runs through, hence contralateral hemiplegia
Eye findings can help distinguish